[The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection].
The adjuvant injection of wide-spectrum immunocorrector leukinferon to 45 males with gonorrheal-chlamydial urogenital infection receiving tarivid and doxicicline made the treatment shorter and the number of inflammatory complications and recurrences less numerous. Leukocyte and lymphocyte counts returned to normal values 6 days earlier and so did immunological indices. In control subjects (20 patients) on immunocorrection with tactivin inflammation persisted longer, urogenital complications were not cured, chlamydial recurrences occurred in 10% of the patients, immunological normalization was not reached.
Kuznetsov
V P
VP
Dubenskiĭ
V V
VV
Delektorskiĭ
V V
VV
Igoshin
Iu M
IuM
Beliaev
D L
DL
Iashkova
G N
GN
Babaiants
A A
AA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D016207:Cytokines / Q000627:therapeutic use*; D004318:Doxycycline / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007370:Interferon Type I / Q000627:therapeutic use*; D008297:Male; D052801:Male Urogenital Diseases / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D015242:Ofloxacin / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D016207:Cytokines; D004338:Drug Combinations; D007370:Interferon Type I; C062252:leukinferon; D015242:Ofloxacin; D004318:Doxycycline
Kompleksnaia terapiia bol'nykh s gonoreĭno-khlamidiĭnoĭ urogenital'noĭ infektsieĭ s immunokorrektsieĭ leĭkinferonom.